Munich Cluster for Systems Neurology
print


Breadcrumb Navigation


Content

Failure of alemtuzumab as a rescue in a NMOSD patient treated with rituximab

Neurol Neuroimmunol Neuroinflamm. 2016 Feb 10;3(2):e208. doi: 10.1212/NXI.0000000000000208. eCollection 2016.

Authors/Editors: Kowarik MC, Hoshi M, Hemmer B, Berthele A.
Publication Date: 2016

Abstract

 

Related Links